PGIM India Healthcare Growth Direct Plan
SIP amount
Min. ₹1,000
Lumpsum amount
Min. ₹5,000

PGIM India Healthcare Growth Direct Plan

NAV
₹9.7400
+0.00%
(3 Oct)
AUM
107 Cr
TER
0.66%
Risk
Very High Risk
Insights
Net Asset Value (NAV) is above its 200 days moving average
In beta. Send feedback here.
Compare with other fund
1Y
-3.5%
-3.9%
-7.2%
NA
NA
3Y
+33.5%
+33.8%
+31.8%
+30.9%
NA
5Y
+31.7%
+33.7%
+34.6%
+29.7%
NA
ALL
+17.0%
+12.0%
+25.0%
+18.2%
-2.6%
VOL
19.7%
20.2%
22.2%
16.3%
13.9%
TER
0.9%
0.8%
0.6%
0.5%
0.7%
AUM
₹1,341 Cr
₹5,179 Cr
₹5,227 Cr
₹7,509 Cr
₹107 Cr
INFO
0.86
0.60
1.13
1.12
-0.19
See fund holdings as of 31st Aug
Top holdings
Sun Pharmaceuticals Industries Ltd
12.3%
Divi's Laboratories Ltd
8.8%
Max Healthcare Institute Ltd Ordinary Shares
7.5%
Dr Reddy's Laboratories Ltd
6.4%
Aster DM Healthcare Ltd Ordinary Shares
5.7%
Mankind Pharma Ltd
5.2%
Torrent Pharmaceuticals Ltd
5.1%
Krishna Institute of Medical Sciences Ltd
3.9%
Abbott India Ltd
3.5%
Global Health Ltd
3.4%
Top industry exposure
Healthcare
90.7%
Financial Services
5.3%
Basic Materials
2.3%
Other information
Minimum SIP
₹1,000
Minimum lumpsum
₹5,000
Additional lumpsum
₹1,000
Portfolio turnover
12%
Lock-in period
-
Exit load
• 0.5% for redemption within 90 days
Fund objective
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns
Fund manager(s)
Puneet Pal
Anandha Padmanabhan Anjeneyan
Utsav Mehta
Vivek Sharma

FAQs